Brought to you by 
Series B leads to $11.5mm for device firm Core Essence Orthopaedics
05 Apr 2011
Executive Summary
Core Essence Orthopaedics Inc. (devices for minimally invasive soft tissue and arthroscopic musculoskeletal repair) raised $11.5mm in its Series B financing led by Baird Venture Partners, which adds a board member. Also participating was Series A backer NewSpring Health Capital, Robin Hood Ventures, and individual investors. The funds will support commercialization activities for the company's soft tissue and skeletal repair devices. Core Essence’s 2008 Series A brought in $5mm.
Deal Industry
- Medical Devices
-
Medical Devices
- Implantable Devices
-
Surgical Equipment & Devices
- Minimally or Less Invasive
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Series B leads to $11.5mm for device firm Core Essence Orthopaedics
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice